Skip to content

WIN 2013 Symposium “Personalized Cancer Therapy: From Innovation to Implementation”

The WIN 2013 Symposium is the fifth in an annual series of multi-sector, worldwide Symposia dedicated to the advancement of personalized cancer medicine. The theme of WIN2013, taking place July 10-12, 2013, in Paris, France, is:

Personalized Cancer Therapy: From Innovation to Implementation

Join leaders from around the world in a collaborative, global forum to learn about and share innovations that represent the most promising advances in personalized cancer care. Globally-recognized experts from academia, pharma, life-sciences, healthcare IT, regulatory, and patient advocacy will present in plenary sessions on:

  • OMICS assays that support personalized clinical care today
    Moderator: Alexander Eggermont, Institut Gustave Roussy (France)
  • Analysis and clinical application of genomics
    Moderator: Levi Garraway, Dana-Farber Cancer Institute (USA)
  • Clinical progress in personalized cancer therapy
    Moderator: Richard L. Schilsky, ASCO (USA)
  • New approaches that impact personalized cancer care
    Moderator: John Mendelsohn, MD Anderson Cancer Center (USA)

WIN2013 is a unique opportunity for all stakeholders in personalized cancer medicine. With extended time for discussion and interaction, the Symposium offers you opportunities to learn from, and network with, leaders from around the globe regarding the most transformational developments in cancer care.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.